Our DiaComp pilot grant was selected for funding

hassanalaliphd
Sep 24, 2021
1 min read

Our pilot award to DiaComp was selected for funding! The goal of this pilot study is to test novel podocyte protective compounds that emerged from a phenotypic screen in an animal model of diabetic kidney disease

Recent Posts

See All

Our NCI RO1 received a 1.0 percentile score!!!

Our NCI R01 (Schatz, Ali) received a 1 percentile score. This grant aims to study the essential role of the cyclin-G associated kinase...

New DoD Funding

The Zeier and Ali labs received a DoD Therapeutic Idea Award. The goal of the project is to evaluate whether the spinal cord injury drug...

New State of Florida Funding

The Ali Lab, in collaboration with the Brambilla lab, received new funding from the State of Florida. The goal of this program is to...

The Ali Lab at the University of Miami

Our DiaComp pilot grant was selected for funding

Recent Posts

Comments